Premium Information is available for this item - Upgrade for $1 a day
6505-00-204-1041
Usp Oxycodone And Aspirin Tablets
6505002041041 002041041 PERC0DANH0SPITALPACK
INC: 49766 Oxycodone And Aspirin Tablets
January 2023
5
Marketplace 6505-00-204-1041
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-204-1041 5+ Documents (More...)
Usp Oxycodone And Aspirin Tablets 002041041 RQST NE Updated Every Day 6505-00-204-1041 RQST Updated
Every Day 6505-00-204-1041 RQST NE Related Documents 6505-00-204-1041 5+ Documents ( More... ) https/
6505-01-211-4661 https https//www.nsnlookup.com https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-204-1041
Usp Oxycodone And Aspirin Tablets 002041041 Usp Oxycodone And Aspirin Tablets 012114661 Oxycodone
Usp Oxycodone And Aspirin Tablets 002041041 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-204-1041
65/fsc-6505/us 6505-01-211-4661 Usp Oxycodone Documents 6505-01 Usp Oxycodone And Aspirin Tablets 002041041
095-8570PERCODAN Tablets 011157566 Usp Oxycodone https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-204-1041
Usp Oxycodone And Aspirin Tablets 002041041 Tablets 002041041 Documents 6505-01 Usp Oxycodone And
Usp Oxycodone And Aspirin Tablets 002041041 6505/us 6505-01-211-4661 Usp Oxycodone And Aspirin
/fsg-65/fsc-6505/us 6505-01-211-4661 Usp Oxycodone And Aspirin Tablets 012114661 Aspirin Tablets 002041041
Restrictions 6505-00-204-1041
6505-00-204-1041 is a Usp Oxycodone And Aspirin Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-00-204-1041
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-204-1041
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
- United States of America (ZZ)
Approved Sources 6505-00-204-1041
- Part Number
- Manufacturer
- Status
- PERC0DANH0SPITALPACK
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Incomplete Reference
- Incomplete Reference
Datasheet 6505-00-204-1041
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 224.000 Milligrams Aspirin Active Ingredient And 32.000 Milligrams Caffeine Active Ingredient And 0.380 Milligrams Homatropine Terephthalate Active Ingredient And 4.500 Milligrams Oxycodone Hydrochloride Active Ingredient And 0.380 Milligrams Oxycodone Terephthalate Active Ingredient And 160.000 Milligrams Phenacetin Active Ingredient
- Primary Container Content Quantity [CRLK]
- 25.000 Tablets
- Primary Container Type [CQCT]
- Carton
- Special Features [FEAT]
- Administration:Oral Nonchewable;
Similar Supply Items to 6505-00-204-1041
Freight Information 6505-00-204-1041
6505-00-204-1041 has freight characteristics.. 6505-00-204-1041 has a variance between NMFC and UFC when transported by rail and the description should be consulted.